Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.

Konstantinos MourouzisGerasimos SiasosEvangelos OikonomouMarina ZaromitidouVicky TsigkouAlexis AntonopoulosEvanthia BletsaPanagiota StampouloglouKonstantinos VlasisManolis VavuranakisDimitris Tousoulis

Published in: Lipids in health and disease (2021)

Elevated Lp-PLA2 levels relate to endothelial dysfunction and arterial stiffness in patients with stable CAD independently from classical risk factors for CAD, statin use, antihypertensive treatment, and duration of the disease.

Keyphrases

coronary artery disease
blood pressure
percutaneous coronary intervention
cardiovascular events
coronary artery bypass grafting
cardiovascular disease
type diabetes
low density lipoprotein
heart failure
smoking cessation